Stealth Company
The problem it says it solves
Built for people using GLP-1 medications such as Ozempic, Wegovy, Mounjaro, and other semaglutide or tirzepatide routines.
Who it says it is for
People using GLP-1 medications
Revenue as published
| Figure | Value | What it means |
|---|---|---|
| Revenue, last 30 days | 35 | USD received in the thirty days before the snapshot |
| Revenue, trailing 12 months | 103 | USD received in the twelve months before the snapshot |
| Monthly recurring revenue | 8 | The recurring part only, as the provider reports it |
Profile
| Founded | 2026-09-01 |
| Country | US |
| Team | 1 person |
| Funding | Bootstrapped |
| Audience | B2C |
| Payment provider | RevenueCat |
Markets Mobile Apps Health & Fitness. Country US.